Clinicopathological characteristics | p21 expression | P value | EGFR expression | P value | ||||
– | + | ++ | – | + | ++ | |||
Age (years) | 0.666 | 0.502 | ||||||
<50 | 830 | 203 | 1441 | 578 | 294 | 543 | ||
≥50 | 3274 | 863 | 5698 | 2490 | 1354 | 2514 | ||
Gender | 0.448 | 0.184 | ||||||
Female | 1647 | 407 | 2869 | 1224 | 617 | 1222 | ||
Male | 2457 | 659 | 4270 | 1844 | 1031 | 1835 | ||
Primary tumour site | <0.001* | 0.479 | ||||||
Rectum | 2250 | 499 | 3792 | 1640 | 852 | 1585 | ||
Distal | 904 | 200 | 1665 | 695 | 390 | 685 | ||
Proximal | 929 | 192 | 1669 | 677 | 376 | 740 | ||
Synchronous | 12 | 175 | 0 | 52 | 27 | 44 | ||
Mucinous subtype | <0.001* | <0.001* | ||||||
Negative | 2777 | 745 | 5501 | 2203 | 1078 | 1856 | ||
Positive | 390 | 79 | 569 | 236 | 101 | 83 | ||
Tumour differentiation | 0.107 | 0.001* | ||||||
Poor | 50 | 14 | 101 | 44 | 21 | 33 | ||
Moderate | 2877 | 751 | 5133 | 2186 | 1176 | 2075 | ||
Well | 1043 | 288 | 1692 | 750 | 418 | 889 | ||
Lymphovascular invasion | 0.025* | <0.001* | ||||||
Negative | 2853 | 757 | 5149 | 2277 | 1170 | 2103 | ||
Positive | 1192 | 306 | 1915 | 785 | 477 | 947 | ||
Perineural invasion | <0.001* | <0.001* | ||||||
Negative | 2920 | 755 | 5373 | 2314 | 1185 | 2095 | ||
Positive | 1130 | 311 | 1707 | 751 | 461 | 956 | ||
Circumferential resection margin | 0.045* | 0.053 | ||||||
Negative | 3615 | 1020 | 6656 | 2971 | 1588 | 2876 | ||
Positive | 85 | 17 | 110 | 35 | 20 | 55 | ||
Tumour size (cm) | 0.215 | 0.005* | ||||||
<4 | 2879 | 733 | 4900 | 2165 | 1167 | 2053 | ||
≥4 | 1206 | 330 | 2209 | 892 | 479 | 995 | ||
T stage | <0.001* | <0.001* | ||||||
Tis | 16 | 5 | 26 | 14 | 8 | 10 | ||
T1 | 152 | 48 | 296 | 150 | 71 | 102 | ||
T2 | 677 | 181 | 1204 | 530 | 266 | 463 | ||
T3 | 940 | 499 | 2649 | 1116 | 903 | 2031 | ||
T4 | 2307 | 331 | 2946 | 1251 | 399 | 440 | ||
N stage | 0.002* | 0.014* | ||||||
N0 | 1929 | 545 | 3634 | 1623 | 825 | 1491 | ||
N1 | 1347 | 332 | 2201 | 937 | 539 | 986 | ||
N2 | 826 | 189 | 1303 | 508 | 284 | 579 | ||
M stage | 0.522 | 0.441 | ||||||
M0 | 3550 | 933 | 6222 | 2661 | 1408 | 2629 | ||
M1 | 554 | 133 | 917 | 407 | 240 | 428 | ||
TNM stage | 0.021* | 0.045* | ||||||
0 | 13 | 4 | 21 | 13 | 7 | 6 | ||
I | 595 | 166 | 1117 | 497 | 241 | 418 | ||
II | 1192 | 334 | 2277 | 1001 | 524 | 959 | ||
III | 1747 | 429 | 2796 | 1147 | 635 | 1241 | ||
IV | 554 | 133 | 917 | 407 | 240 | 428 | ||
Mismatch repair | <0.001* | 0.609 | ||||||
pMMR | 3087 | 956 | 6159 | 2824 | 1522 | 2806 | ||
dMMR | 895 | 103 | 892 | 225 | 114 | 236 | ||
Microsatellite instability | 0.402 | 0.197 | ||||||
MSS | 37 | 15 | 94 | 46 | 29 | 41 | ||
MSI-H | 5 | 1 | 8 | 2 | 6 | 3 | ||
MSI-L | 1 | 2 | 3 | 1 | 1 | 3 | ||
KRAS | 0.639 | 0.449 | ||||||
Wild type | 443 | 194 | 627 | 345 | 267 | 499 | ||
Mutant type | 382 | 148 | 520 | 277 | 214 | 448 | ||
NRAS | 0.595 | 0.95 | ||||||
Wild type | 684 | 326 | 997 | 549 | 469 | 911 | ||
Mutant type | 23 | 10 | 25 | 17 | 13 | 26 | ||
BRAF | 0.166 | 0.004* | ||||||
Wild type | 729 | 326 | 996 | 568 | 463 | 882 | ||
Mutant type | 23 | 12 | 50 | 10 | 17 | 47 |
– represents negative, + represents weakly positive, ++ represents positive.
*P<0.05.
dMMR, deficient mismatch repair; MSI-H, high microsatellite instability; MSI-L, low microsatellite instability; MSS, microsatellite stability; pMMR, proficient mismatch repair; TNM, tumour, node, metastases.